Format

Send to

Choose Destination
AIDS Care. 2018 Aug;30(8):954-962. doi: 10.1080/09540121.2018.1427207. Epub 2018 Jan 18.

Quality of life among HIV-infected individuals failing first-line antiretroviral therapy in resource-limited settings.

Author information

1
a Center for Biostatistics in AIDS Research , Harvard T. H. Chan School of Public Health , Boston , MA , USA.
2
b LAPCLIN-AIDS, Instituto Nacional de Infectologia Evandro Chagas (INI-FIOCRUZ) , Rio de Janeiro , Brazil.
3
c Asociación Civil Impacta Salud y Educación , Lima , Peru.
4
d Department of Psychology , University of Miami , Miami , FL , USA.
5
e UNC Project Lilongwe , Lilongwe , Malawi.
6
f YRGCARE Medical Centre, VHS , Chennai , India.
7
g Department of Medicine , University of Zimbabwe-University of California Collaborative Research Programme , Harare , Zimbabwe.
8
h Department of Medicine , University of Washington , Seattle , WA , USA ; for AIDS Clinical Trials Group (ACTG) A5273 Study Group.

Abstract

We evaluated health-related quality of life (QoL) in HIV infection participants with virologic failure (VF) on first-line antiretroviral therapy (ART) in 9 resource-limited settings (RLS). ACTG SF-21 was completed by 512 participants at A5273 study entry; 8 domains assessed: general health perceptions (GHP), physical functioning (PF), role functioning (RF), social functioning (SF), cognitive functioning (CF), pain (P), mental health (MH), and energy/fatigue (E/F); each was scored between 0 (worst) to 100 (best). Mean QoL scores ranged from 67 (GHP) to 91 (PF, SF, CF). QoL varied by country; high VL and low CD4 were associated with worse QoL in most domains, except RF (VL only), SF (CD4 only) and CF (neither). Number of comorbidities, BMI and history of AIDS were associated with some domains. Relationships between QoL and VL varied among countries for all domains. The association of worse disease status with worse QoL may reflect low QoL when ART was initiated and/or deterioration associated with VF.

KEYWORDS:

HIV; Health-related quality of life; antiretroviral therapy; resource-limited settings; virologic failure

PMID:
29343078
PMCID:
PMC6100767
[Available on 2019-08-01]
DOI:
10.1080/09540121.2018.1427207

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center